About Contact Us Careers

Duchenne Muscular Dystrophy Treatment Market Trends

Request Free Sample Copy

Report ID: 3814
Published Date: Aug 22, 2024
Report Format: PDF, PPT

Buy Now

Duchenne Muscular Dystrophy Treatment Market Trends

Growth Drivers

Rising Prevalence of Musculoskeletal Disorders
High Share of Male Population Globally
Increasing R&D Activities in Healthcare Sector

Challenges

Difficult Diagnosis of the Disease
Lack of Health Awareness amongst People in Undeveloped Regions

Duchenne Muscular Dystrophy Treatment Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	11.8%
Base Year Market Size (2023)	USD 3.12 billion
Forecast Year Market Size (2036)	USD 13.3 billion
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Duchenne Muscular Dystrophy Treatment Market Size Forecasts 2036

Author Credits: Radhika Pawar

Report ID: 3814
Published Date: Aug 22, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of duchenne muscular dystrophy treatment is assessed at USD 3.41 billion.

Duchenne Muscular Dystrophy Treatment Market size was valued at USD 3.12 billion in 2023 and is expected to exceed USD 13.3 billion by 2036, expanding at over 11.8% CAGR during the forecast period i.e., between 2024-2036. Increasing incidences of DMD, and the emergence of mutation-specific therapies will boost the market growth.

Asia Pacific industry is anticipated to account for largest revenue share by 2036, due to high prevalence of musculoskeletal diseases in the region.

The major players in the market are Eli Lilly and Company, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Johnson & Johnson Services, Inc., Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and others.

Inquiry Before Buying Request Free Sample